Ask My Investor AI
Public company · NYSEPublished company research
VLTO

Identity verified against SEC EDGAR filing 0001967680-26-000011; registered as Veralto Corp, CIK 0001967680.

Veralto Corporation

Veralto is a large water-quality and product-quality platform with Q1 2026 sales of $1.422 billion and a Water Quality segment spanning instruments, treatment, disinfection and data. The reviewed official sources do not identify a PFAS-specific analyzer, treatment product, contract or revenue stream. Any PFAS benefit is therefore an adjacent monitoring hypothesis, not direct verified exposure, and the subject remains NOT_READY.

Ask follow-up research
Reviewed company research · researched 2026-07-29 · not an individual investment recommendation
Listing
public
Ticker
VLTO
Exchange
NYSE
HQ
United States
Currency
USD
SEC CIK
0001967680
Investment case

How this company captures the theme economics

Competitive position

Hach, Trojan, ChemTreat, Aquatic Informatics and other Water Quality brands provide broad municipal and industrial measurement and treatment capability. No reviewed official source directly connects a named Veralto product or contract to PFAS, so the mapped relationship fails its product-capability gate.

Scarce assets

Scarce assets in this value chain include accredited pfas laboratory capacity (low-ppt lc-ms/ms analysis) as monitoring mandates scale to 2027, pfas-selective ion-exchange resin supply and regeneration capability (claimed 30-40% lifecycle-cost advantage over gac), rcra-permitted high-temperature incineration capacity with validated otm-50/method 0010 emissions performance - concentrated in very few operators.

Products, segments, and customers

Veralto reports Water Quality and Product Quality & Innovation. Water Quality includes analytical instruments, chemical treatment, ultraviolet disinfection and water-data platforms; Q1 2026 Water Quality sales grew 10.1% reported and 3.8% core.

Theme capture

No direct PFAS product or contract is verified. Compliance monitoring may create adjacent demand, but that inference is insufficient for a direct PFAS claim and fails closed.

Conditions

What must be true

  1. Search Veralto filings and Hach product catalogs for PFAS-specific analyzers, sampling or data offerings; question whether UCMR/NPDWR monitoring spend flows to field instrumentation at all.
  2. The exposure described for Veralto must be confirmed as financially material in official filings.

Identifiable catalysts

  • Forthcoming quarterly and annual issuer filings
  • Theme-level catalysts detailed in the PFAS treatment, destruction and liability transfer brief
Theme materiality

2 mapped themes

Exposure statements are evidence-qualified. Materiality is only claimed where disclosure supports it.

Water quality analytics and instrumentation platform (Hach, Trojan, ChemTreat, Aquatic Informatics) serving municipal and industrial monitoring - the detection/monitoring layer of the theme.

PFAS treatment, destruction and liability transfer

Adjacent and unverified for PFAS. Official sources confirm a large Water Quality platform and current segment growth but do not identify a PFAS-specific product, service, contract or financial contribution.

Evidence
The Water Quality page and Q1 2026 results directly support brand scope and segment scale. Their absence of a PFAS-specific offering means direct product capability is not supported and the relationship fails closed.
Materiality
not assessed — No official evidence of PFAS-specific products, contracts, revenue, orders or margins; the relationship remains an adjacent hypothesis.
Water quality analytics, monitoring and specialty water treatment (Hach, ChemTreat, Trojan Technologies, Aquatic Informatics, OTT HydroMet).

Wastewater as a resource-recovery platform

High and direct in the measurement/analytics and disinfection layer. Veralto's Water Quality segment (~60% of ~USD 5.5bn FY2025 revenue) provides instruments, sensors, UV disinfection, chemistry and data platforms used across municipal and wastewater treatment, including discharge-compliance and reuse monitoring.

Evidence
Water Quality segment brands and wastewater/reuse relevance confirmed from Veralto's Water Quality page (src-09); revenue and segment-share figures surfaced via search of Veralto disclosures. Theme-specific revenue not isolated.
Materiality
estimated — Segment scale is disclosed and highly relevant to monitoring/compliance for reuse, but wastewater-recovery-specific revenue is not separately reported.
Financial evidence

Official SEC filing evidence

Reference period: FY2025 and Q1 2026.

  • Operating income$1.28 billion
    FY2025[1]
  • EBITDA$1.35 billion
    FY2025[1]
  • Diluted EPS$3.76
    FY2025[1]
  • Operating cash flow$1.08 billion
    FY2025[1]
  • Free cash flow$1.01 billion
    FY2025[1]
  • Cash and equivalents$2.03 billion
    FY2025 year-end[1]
  • Sales$1.422 billion
    Q1 2026[2]
  • Operating profit$338 million
    Q1 2026[2]
  • Net earnings$254 million
    Q1 2026[2]

Limitation: Filing evidence establishes scale, profitability, cash generation, and leverage. Market-derived valuation is withheld until a licensed market-data feed is connected, and theme materiality is stated separately.

Risks

Material risks and break conditions

Material risks

  • Finalized partial rescission removes four of six regulated compounds, shrinking treated-compound scope and some testing/treatment demand
  • Compliance-deadline extension to 2031 (or further slippage) defers utility capex and pressures near-term equipment and media orders

Thesis-break conditions

  • Final rule or court decision rescinds, vacates or raises the PFOA/PFOS MCLs above 4.0 ppt
  • Compliance deadline extended beyond April 2031 or exemptions made effectively open-ended
Investability conclusion

Where the evidence lands

NOT_READY. Official sources verify identity, current financial scale and broad Water Quality capability, but do not directly support a PFAS product or contract. Product capability, PFAS materiality, current licensed valuation and human reviewer acceptance remain unresolved; no subject acceptance or recommendation is permitted.

Next diligence

  1. Search Veralto filings and Hach product catalogs for PFAS-specific analyzers, sampling or data offerings; question whether UCMR/NPDWR monitoring spend flows to field instrumentation at all.
  2. Break out wastewater/reuse-linked instrument, UV (Trojan) and SaaS revenue; assess PFAS/micropollutant monitoring opportunity under EU quaternary-treatment rules.
Source ledger

Identity and evidence sources

Identity was verified against official issuer, filing, exchange, or regulator sources where available.

  1. Veralto Corp FY2025 Form 10-KSEC EDGAR · primary · published 2026-02-20 · accessed 2026-07-22
  2. Veralto Reports First Quarter 2026 ResultsVeralto Corporation · primary · published 2026-04-28 · accessed 2026-07-29
  3. Water QualityVeralto Corporation · primary · published undated · accessed 2026-07-29